Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
03/11/2004 | DE10240343A1 Peroxynitrit-Umlagerungskatalysatoren Peroxynitrite rearrangement catalysts |
03/11/2004 | CA2496948A1 Il-14 vaccine for the treatment of asthma and atopic disorders |
03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
03/11/2004 | CA2496607A1 Vaccine comprising il-13 and an adjuvant |
03/11/2004 | CA2496459A1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
03/11/2004 | CA2496447A1 Amelioration of effects of cigarette smoke |
03/11/2004 | CA2496409A1 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |
03/11/2004 | CA2495437A1 Novel crystal |
03/11/2004 | CA2493199A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
03/11/2004 | CA2492645A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative |
03/10/2004 | EP1396266A1 Aqueous cilostazol preparation for injection |
03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
03/10/2004 | EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions |
03/10/2004 | EP1395607A2 Respiratory syncytial virus |
03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
03/10/2004 | EP1395590A2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]indole derivatives as prostaglandin d2 receptor antagonists |
03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
03/10/2004 | EP1395581A2 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
03/10/2004 | EP1395575A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
03/10/2004 | EP1395574A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
03/10/2004 | EP1395558A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
03/10/2004 | EP1395554A1 Substituted carbazoles as inhibitors of spla2 |
03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
03/10/2004 | EP1395538A1 Vitamin d analogues |
03/10/2004 | EP1395288A1 A pde 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
03/10/2004 | EP1395287A1 An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases |
03/10/2004 | EP1395277A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis |
03/10/2004 | EP1395269A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
03/10/2004 | EP1236725B1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
03/10/2004 | EP0868198B1 FCepsilon-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
03/10/2004 | EP0804435B1 Novel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
03/10/2004 | CN1481387A Condensed purine derivatives as A1 adenosine receptor antagonists |
03/10/2004 | CN1481383A Method for producing anticholinergic agent tiotropium bromide |
03/10/2004 | CN1481379A Substituted pyrrolidines as CCR-3 receptor antagonists |
03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
03/10/2004 | CN1481370A Quinazoline derivatives, medicaments contg. said compounds, their utilization and method for prodn. thereof |
03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
03/10/2004 | CN1481256A Inhalation of nitric oxide |
03/10/2004 | CN1481246A Preventives/ermedies for inflammatory airway diseases |
03/10/2004 | CN1481244A Pharmaceutical formulation contg pyrazolo [4,3-D] pyrinidines, calcium antagonists, prostaglandins or prostaglandin derivatives |
03/10/2004 | CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
03/10/2004 | CN1480455A 'Sqiqu site' ramification and its preparing method as well as its activity of anti asthma |
03/10/2004 | CN1480454A Antagon of endostadin receptor pyrazole carboxylic acids |
03/10/2004 | CN1480213A Effect of transfer factor and substance of small peptides restraining SARS virus fully |
03/10/2004 | CN1480194A Oral liquid for anti SARS virus |
03/10/2004 | CN1480191A Prophylaxis medication for treating pneumonia, bronchitis, pharyngitis and upper respiratory tract infection as well as its preparing method |
03/10/2004 | CN1480189A Medication for treating rhinitis |
03/10/2004 | CN1480177A Preparation to be taken after being mixed with boiling water for easy to release symptom of cough and asthma caused by SARS and its prepn. method |
03/10/2004 | CN1480141A Preparation of theophylline or aminophylline supplied through skin for treating respiratory disease as well as its preparing method |
03/10/2004 | CN1480134A Combination of iodine amino acid as well as its preparation method and application |
03/10/2004 | CN1141131C Medicine for treating chronic pharyngitis |
03/10/2004 | CN1141130C Medicine for treating tonsillitis and its prepn. process |
03/10/2004 | CN1141117C Wine for treating injury |
03/10/2004 | CN1141095C Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethy1)-anilid and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
03/09/2004 | US6703389 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
03/09/2004 | US6703376 Administering to the airways of the patient a uridine phosphate such as uridine 5'triphosphate or di(uridine5') tetraphosphate for promoting drainage of mucous secretions in the congested airways of a bedridden/immobilized patient |
03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
03/09/2004 | US6702997 Premeasured single unit dose; may be free of anti-microbial preservatives, such as benzalkonium chloride. |
03/09/2004 | US6702803 Multi-step drug dosage forms |
03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
03/04/2004 | WO2004018465A2 Benzonaphthyridines with pde 3/4 inhibiting activity |
03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
03/04/2004 | WO2004018457A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
03/04/2004 | WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors |
03/04/2004 | WO2004018450A1 Piperidine-n-oxide-derivatives |
03/04/2004 | WO2004018434A1 Pyrimidine compounds |
03/04/2004 | WO2004018431A2 Novel phenanthridines |
03/04/2004 | WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME |
03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
03/04/2004 | WO2004018025A1 Pharmaceutical compositions |
03/04/2004 | WO2004017994A1 Preventive and/or therapeutic drugs for asthma |
03/04/2004 | WO2004017993A1 Combination of prostacyclin or prostacyclin analogues and endothelin receptor antagonists for the treatment of pulmonary arterial hypertension |
03/04/2004 | WO2004017974A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
03/04/2004 | WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain |
03/04/2004 | WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
03/04/2004 | WO2004017948A2 Use of lck inhibitor for treatment of immunologic diseases |
03/04/2004 | WO2003105908A9 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
03/04/2004 | WO2003094960A3 Mucosal combination vaccines for bacterial meningitis |
03/04/2004 | WO2003065044A3 Diagnostics and therapeutics for diseases associated with gpr72 |
03/04/2004 | WO2003050067A3 Vitamin d analogues |
03/04/2004 | WO2003042214A3 A2b adenosine receptor antagonists |
03/04/2004 | WO2003039566A3 Methods of treatment in situ in the lungs of mammals |
03/04/2004 | WO2003026629A3 Modified release dosage forms |
03/04/2004 | WO2003024928A3 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |